Article Text
Therapeutics
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Statistics from Altmetric.com
Question
In patients with peripheral artery disease (PAD), does aspirin reduce cardiovascular (CV) events?
Review scope
Included studies compared aspirin with placebo or control for reducing CV events in patients with PAD. Outcomes were a composite end point of non-fatal myocardial infarction (MI), non-fatal stroke, and CV mortality; individual components of the composite end point; all-cause …
Footnotes
Source of funding: National Heart, Lung, and Blood Institute.